Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.

Therapeutic proteins are derived from complex expression/production systems, which can result in minor conformational changes due to preferential codon usage in different organisms, post-translational modifications, etc. Subtle conformational differences are often undetectable by bioanalytical metho...

Full description

Bibliographic Details
Main Authors: Ran Zichel, Wanida Chearwae, Gouri Shankar Pandey, Basil Golding, Zuben E Sauna
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3288073?pdf=render
_version_ 1828873935457878016
author Ran Zichel
Wanida Chearwae
Gouri Shankar Pandey
Basil Golding
Zuben E Sauna
author_facet Ran Zichel
Wanida Chearwae
Gouri Shankar Pandey
Basil Golding
Zuben E Sauna
author_sort Ran Zichel
collection DOAJ
description Therapeutic proteins are derived from complex expression/production systems, which can result in minor conformational changes due to preferential codon usage in different organisms, post-translational modifications, etc. Subtle conformational differences are often undetectable by bioanalytical methods but can sometimes profoundly impact the safety, efficacy and stability of products. Numerous bioanalytical methods exist to characterize the primary structure of proteins, post translational modifications; protein-substrate/protein/protein interactions and functional bioassays are available for most proteins that are developed as products. There are however few analytical techniques to detect changes in the tertiary structure of proteins suitable for use during drug development and quality control. For example, x-ray crystallography and NMR are impractical for routine use and do not capture the heterogeneity of the product. Conformation-sensitive antibodies can be used to map proteins. However the development of antibodies to represent sufficient epitopes can be challenging. Other limitations of antibodies include limited supply, high costs, heterogeneity and batch to batch variations in titer. Here we provide proof-of-principle that DNA aptamers to thrombin can be used as surrogate antibodies to characterize conformational changes. We show that aptamers can be used in assays using either an ELISA or a label-free platform to characterize different thrombin products. In addition we replicated a heat-treatment procedure that has previously been shown to not affect protein activity but can result in conformational changes that have serious adverse consequences. We demonstrate that a panel of aptamers (but not an antibody) can detect changes in the proteins even when specific activity is unaffected. Our results indicate a novel approach to monitor even small changes in the conformation of proteins which can be used in a routine drug-development and quality control setting. The technique can provide an early warning of structural changes during the manufacturing process that could have consequential outcomes downstream.
first_indexed 2024-12-13T07:26:42Z
format Article
id doaj.art-9b26de341a5946ec92d06426ff1f09fd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T07:26:42Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9b26de341a5946ec92d06426ff1f09fd2022-12-21T23:55:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0172e3194810.1371/journal.pone.0031948Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.Ran ZichelWanida ChearwaeGouri Shankar PandeyBasil GoldingZuben E SaunaTherapeutic proteins are derived from complex expression/production systems, which can result in minor conformational changes due to preferential codon usage in different organisms, post-translational modifications, etc. Subtle conformational differences are often undetectable by bioanalytical methods but can sometimes profoundly impact the safety, efficacy and stability of products. Numerous bioanalytical methods exist to characterize the primary structure of proteins, post translational modifications; protein-substrate/protein/protein interactions and functional bioassays are available for most proteins that are developed as products. There are however few analytical techniques to detect changes in the tertiary structure of proteins suitable for use during drug development and quality control. For example, x-ray crystallography and NMR are impractical for routine use and do not capture the heterogeneity of the product. Conformation-sensitive antibodies can be used to map proteins. However the development of antibodies to represent sufficient epitopes can be challenging. Other limitations of antibodies include limited supply, high costs, heterogeneity and batch to batch variations in titer. Here we provide proof-of-principle that DNA aptamers to thrombin can be used as surrogate antibodies to characterize conformational changes. We show that aptamers can be used in assays using either an ELISA or a label-free platform to characterize different thrombin products. In addition we replicated a heat-treatment procedure that has previously been shown to not affect protein activity but can result in conformational changes that have serious adverse consequences. We demonstrate that a panel of aptamers (but not an antibody) can detect changes in the proteins even when specific activity is unaffected. Our results indicate a novel approach to monitor even small changes in the conformation of proteins which can be used in a routine drug-development and quality control setting. The technique can provide an early warning of structural changes during the manufacturing process that could have consequential outcomes downstream.http://europepmc.org/articles/PMC3288073?pdf=render
spellingShingle Ran Zichel
Wanida Chearwae
Gouri Shankar Pandey
Basil Golding
Zuben E Sauna
Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
PLoS ONE
title Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
title_full Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
title_fullStr Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
title_full_unstemmed Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
title_short Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.
title_sort aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins
url http://europepmc.org/articles/PMC3288073?pdf=render
work_keys_str_mv AT ranzichel aptamersasasensitivetooltodetectsubtlemodificationsintherapeuticproteins
AT wanidachearwae aptamersasasensitivetooltodetectsubtlemodificationsintherapeuticproteins
AT gourishankarpandey aptamersasasensitivetooltodetectsubtlemodificationsintherapeuticproteins
AT basilgolding aptamersasasensitivetooltodetectsubtlemodificationsintherapeuticproteins
AT zubenesauna aptamersasasensitivetooltodetectsubtlemodificationsintherapeuticproteins